跳至主要内容
临床试验/CTRI/2025/05/086271
CTRI/2025/05/086271尚未招募2/3 期

A clinical study of mutraja vikrita kleda and efficacy of Kataka beeja churna with special reference to routine urine examination.

Dr Dhanwantari Behera2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年5月17日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
2
主要终点
To assess the effect of Kataka beeja churna in mutraja vikrita kleda includes diseases like diabetes mellitus with nephropathy and chronic renal failure without diabetes mellitus.

研究概览

简要总结

This is a clinical study of Kataka beeja churna in the management of mutraja vikrita kleda where 2 groups of diseases will be taken namely chronic renal failure with diabetic nephropathy and chronic renal failure without diabetes mellitus.This study has also includes the objective to find the relation between mutraja vikrita kleda with the abnormalities of urine.Also an in vitro study is done to see the nephroprotective effect of Katak beej.This study is done as a mandatory post graduation thesis work.Total no of patients will be 60 to be studied for 45 days.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients within the age of 18 to 70 years of both sexes having symptoms of Mutraja Vikrita Kleda will be taken.
  • All the selected patients who well give their consent for clinical study will be included.
  • Patient with diagnosed case of chronic renal failure (CRF) with proteinuria
  • Patient with clinical symptoms of diabetic nephropathy.

排除标准

  • Patients below 18 years and above 70 years, pregnant women and lactating mother.
  • Complicated chronic renal failure patients.
  • Patient with Sr. Creatinine more than 6mg/dl
  • Patient with the other systemic complication where needs other intervention.
  • Patient with systemic diseases and immunocompromised states like HIV, TB, Hepatitis B, Hepatitis C
  • Patients with malignancy.

结局指标

主要结局

To assess the effect of Kataka beeja churna in mutraja vikrita kleda includes diseases like diabetes mellitus with nephropathy and chronic renal failure without diabetes mellitus.

时间窗: 45 days

次要结局

  • An invitro study will be conducted to see the nephroprotective effect of Katak beej.(08 months)

研究者

发起方
Dr Dhanwantari Behera
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Dhanwantari Behera

Govt Ayurvedic College And Hospital Guwahati Assam

研究点 (2)

Loading locations...

相似试验